Synthetic blood: First human trials to take place in Scotland

May 31, 2013
px Donated blood e
CREDIT: Antonio, Siempre hace falta sangre / Always need blood via Wikimedia Commons.
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

The following is an excerpt.

Researchers have been given a licence to use stem cells to manufacture blood that could eventually be tested on people.

Synthetic blood would help end supply shortages and prevent infections being passed on through donations.

The Scottish National Blood Transfusion Service, Edinburgh University and Roslin Cells are conducting the work.

The licence, granted by the UK’s Medicines and Healthcare products Regulatory Agency (MHRA), means a manufacturing facility can be set up to work on human cell therapy products.

It will be based at the Scottish Centre for Regenerative Medicine (SCRM) and aims to produce blood which would be fit for clinical trials.

Read the full story here: Go-ahead to develop synthetic human blood in Scotland

Additional Resources:

For additional coverage of the Scottish first:

Scotland is not the first to try to produce artificial blood, however. Earlier this year, India’s IIT Madras geared up for mass production of red blood cells from stem cells.

 

 

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend